id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-034640-ygtbuy4k	nan	Corrigenda	2020-11-04		.txt	text/plain	264	27	45	key: cord-034640-ygtbuy4k authors: nan cord_uid: ygtbuy4k This is highlighted by preliminary findings in a recent study demonstrating the efficacy of dexamethasone in reducing mortality in critically ill patients with COVID-19, but showing no benefit in those not requiring respiratory support. 4 Furthermore, our study 5 demonstrated a ''dose-response,'' with greater degrees of respiratory allergy being associated with larger reductions in angiotensin-converting enzyme 2 gene expression in the nasal epithelium, and the impact of suppressing type 2 inflammation in these individuals is not currently known. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2 The names were shown as Gregori Silvia, PhD, and Aiuti Alessandro, MD, PhD. The first and last names of both authors were inadvertently reversed and should be Silvia Gregori	./cache/cord-034640-ygtbuy4k.txt	./txt/cord-034640-ygtbuy4k.txt